Information Provided By:
Fly News Breaks for May 21, 2018
BMY
May 21, 2018 | 07:42 EDT
UBS analyst Marc Goodman downgraded Bristol-Myers to Neutral from Buy. Goodman lowered his price target to $57 from $67 on Bristol-Myers shares.